Key result
Excessive NLRP3 inflammasome activation drives persistent inflammation and myocardial cell death in HF.
Why the study?
Heart failure morbidity and mortality continue to rise, and persistent cardiac inflammation significantly contributes to adverse cardiac remodeling.
Design
Review
Authors
Loading...
Supports NLRP3 targeting in HF; leaves open clinical validation of inhibitors.
This review highlights the pathogenic role of persistent cardiac inflammation and the NLRP3 inflammasome in heart failure, providing a theoretical basis for targeted anti-inflammatory therapies.
Han et al. (2025) studied this question. Excessive activation of the NLRP3 inflammasome significantly contributes to persistent inflammation and myocardial cell death in heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: